2025 CGA-IGC Annual Meeting
Legend | Scientific Sessions |
Committee Meetings & Social Events | |
Abstract | |
Sponsored Symposium *All Industry Symposia will be held in a separate hall from the plenary hall. |
THURSDAY, OCTOBER 9 | |
---|---|
Time Slot | Meeting Hall |
07:00 - 07:45 | Slot for Tier 2 Sponsored Breakfast Symposium |
08:00 - 08:15 | Welcome & Housekeeping Beth Dudley Yurkovich, CGA-IGC President |
08:15 - 09:00 | Session I: James Church Lecture Moderator: Matthew Kalady Introduction, Matthew Kalady James Church Lecture: A Short History of CGA-IGC, James Church Q&A |
09:00 - 09:55 | Session II: Debate Moderator: Marianne Dubard-Gault Is Bigger Really Better? Debating Genetic Test Panel Size, Maegan Roberts & Dana Farengo-Clark |
09:55 - 10:15 | AM BREAK |
10:15 - 12:15 | Session III: Advocacy Moderators: Emma Keel & Gautam Mankaney Addressing Financial Toxicity For Patients With Hereditary GI Syndromes, Yvonne Bombard Q&A Healthcare Policy Advocacy For Hereditary GI Syndromes, Swati Patel Q&A Genetic Counselor Advocacy: Creating A Seat At The Table, Sara Pirzadeh-Miller Q&A, Using Patient Advocacy To Fight For Change, Ben White Q&A |
12:15 - 13:30 | LUNCH BREAK |
12:20 - 13:20 | Slot for Tier 1 Sponsored Lunch Symposium |
13:30 - 15:00 | Presidential Plenary I Moderators: Bryson Katona & Beth Dudley Yurkovich Financial Distress Among Young Adults With Early-Onset Gastrointestinal Cancers: A Call To Action, Marta Puzzono Genetic Cancer Prevention Clinic: Clinical Outcomes Review, Jacqueline Mersch Mutyh-Associated Polyposis In Adolescents: A Case Series, Kristin Zelley Cigarette Smoking And Age Of Pancreatic Adenocarcinoma Diagnosis For Hereditary Pancreatic Cancer Patients, Timothy Shu Repeat Gastric Body And Antrum Biopsies In Lynch Syndrome Yield Newly Identified Gastric Intestinal Metaplasia, Jessica Vadaketh Cancer Penetrance Among CTNNA1 Loss-Of-Function Carriers: Initial Cancer Risk Estimates From The CTNNA1 Familial Expansion (CAFÉ) Study, Dana Farengo-Clark DNA Mismatch Repair Deficiency And Clinical Features Of Prostate Cancer Among Lynch Syndrome Patients, Linda Rodgers-Fouche Spatially Resolved Transcriptomic Analysis Of Gastric Precancers Arising In Germline CDH1 Variant Carriers, Jeremy Davis Analysis Of Missense Variants In RPS20 And An Association With Colorectal Cancer Predisposition, Jennifer Herrera-Mullar Evaluating The Diagnostic Yield Of Updated Genetic Testing In Individuals With Idiopathic Adenomatous Polyposis, Blake Rowell |
15:00 - 15:40 | PM BREAK 15:05 - 15:35 CCARE Lynch Poster Walk |
15:40 - 17:00 | Session IV: Oncology Moderators: Mo Abbas & Darryl Outlaw Watch And Wait: Management Of Mismatch Repair Proficient Rectal Cancer, Rodrigo Oliva Perez Q&A Non-Operative Management Of Mismatch Repair Deficient Cancers, Zsofia Stadler Q&A How We Do It: DPYD variant testing prior to the use of fluoropyrimidine-based chemotherapy among GI cancer patients: An exploration of current approaches and opportunities for increased Genetic Counselor involvement, Madeline Smith & Daniel Hertz & Arravinth Anantharajah & Heather Glessner Q&A |
17:00 - 18:00 | Session V: Hereditary Live Moderator: Joshua Sommovilla & David Liska Panelists: Lisen Axell & Brian Sullivan & Maria McGreevy |
18:00 - 19:00 | Poster Session I |
FRIDAY, OCTOBER 10 | |
---|---|
Time Slot | Meeting Hall |
07:00 - 07:45 | Slot for Tier 2 Sponsored Breakfast Symposium |
08:00 - 08:15 | Welcome & Housekeeping Beth Dudley Yurkovich, CGA-IGC President |
08:15 - 10:00 | Session VI: Lynch Syndrome Moderators: Chinedu Ukaegbu & Sheila Rustgi What's Different About Lynch-Associated Gynecologic Cancers?, Ying Liu Q&A Lynch Syndrome Network Consensus (Lynsync) International Guidelines, Giulia Martina Cavestro Q&A Capp3: An Update On Aspirin Chemoprevention In Lynch Sydnrome, John Burn Q&A Emerging Treatments For Lynch-Related Cancers, Asaf Maoz Q&A |
10:00 - 10:20 | AM BREAK |
10:20 - 11:05 | Session VII: Anne Krush Lecture Moderator: Cathryn Koptiuch Introduction, Cathryn Koptiuch Anne Krush Lecture: Clinical Management For Variants With Discrepant Classifications, Wendy Kohlmann Q&A |
11:05 - 12:15 | Session VIII: Delivery of Care Moderators: Lauren Gima & Jennifer Fijor Reducing Diparities In Cancer Outcomes For Local Communities: The Cancer Care Equity Program, Ludmila Svoboda Q&A How We Do It: Leveraging Innovation to Improve Access to Hereditary Cancer Genetic Testing in an NP Led Clinic, Ashley Hendershot & Carol Shaw & Patricia Mallaber Q&A Integrating Genetic Social Work to Address Psychosocial Challenges in Hereditary Cancer Care, Emily Epstein |
12:15 - 13:30 | LUNCH BREAK |
12:20 - 13:20 | Slot for Tier 1 Sponsored Lunch Symposium |
13:30 - 15:00 | Presidential Plenary II Moderators:Beth Dudley Yurkovich & Elana Levinson Evaluation Of An Employer-Based Cancer Benefit Program Facilitated By Genetic Counselors, Kelly Knickelbein Assessment Of Reasons For Pancreatic Cancer Surveillance Cessation Or Deferral Amongst High-Risk Individuals, Grace Snyder Expanding The Spectrum: Extra-Colonic Malignancies In MUTYH-Associated Polyposis, Lisa A Laguardia Comparing And Contrasting Lived Experiences Of Patients With Lynch Syndrome And Polyposis Syndromes, John Krebsbach The Longest Documented Follow-Up Of A Large Ampullary Adenoma In FAP: A 30-Year Cancer-Free Case, Youssef Soliman Post Operative Outcomes Of CDH1 Carriers Undergoing Gastrectomy– Results Form The GASTRIC Consortium, Ajay Bansal Real World Adherence To Colorectal Cancer Screening In Patients With MLH1 And MSH2 Lynch Syndrome At A Tertiary Community Cancer Center, Marianne Dubard-Gault Identifying Barriers To Hispanic/Latino Participation In Cancer Clinical Trials: A Pilot Study, José G. Guillem Who’s In The Driver’s Seat? Assessment Of Germline Drivers Of Early-Onset Endometrial Cancer, Juliet Milani Rate And Root Cause Analysis Of Post-Colonoscopy Colorectal Cancer In Lynch Syndrome: The Potential Of The LINEAGE Consortium, Minh Do Cancer Risk In Individuals With Hamartomatous Polyposis Syndromes: A Call For Collaboration, Bryson Katona Perceptions Of Gastric Cancer Risk And Attitudes Towards Endoscopic Surveillance In Patients With CDH1 Pathogenic Variants, Conner Lombardi |
15:00 - 15:20 | PM BREAK |
15:20 - 16:50 | Session VIII: Surveillance and Prevention Moderators: Rachel Hodan & Dan Chung Dermatologic Findings In Hereditary Gi Syndromes: Diagnosis And Surveillance, Ata Moshiri Q&A Using Molecular Cyst Fluid Analysis For Risk Stratification In Hereditary Pancreatic Cancer Surveillance, Aatur Singhi Q&A How Do Different Endoscopic Techniques Affect Colonoscopy Outcomes?, Pooja Dharwadker Q&A |
17:00 - 18:00 | Session IX: Jeopardy Moderators: Mike Hall & Kim Hilfrank |
18:00 - 19:00 | Poster Session II |
SATURDAY, OCTOBER 11 | |
---|---|
Time Slot | Meeting Hall |
07:00 - 07:45 | Slot for Tier 2 Sponsored Breakfast Symposium |
08:00 - 08:15 | Welcome & Housekeeping Beth Dudley Yurkovich, CGA-IGC President |
08:15 - 09:00 | Session X: Charis Eng Lecture Moderator: Brandie Leach Introduction, Brandie Leach Charis Eng Lecture: What You Should Know About PTEN, Joanne Ngeow Q&A |
09:00 - 10:30 | Session XI: Upper GI Management Moderators: Jennifer Weiss & Joshua Melson Spigelman Classification: Is It Time For A Change?, Alessandro Mannucci Q&A Implications Of Metabolic Surgery And Medication In Patients With Hereditary GI Syndromes, Rickesha Wilson Q&A Surgical Management Of Duodenal And Ampullary Lesions, Dominic Sanford Q&A |
10:30 - 10:50 | AM BREAK |
10:50 - 12:15 | Session XII: Population Based Testing Moderators: Julie Moskowitz & Heather Hampel The Current State Of Population Based Genetic Testing, Stephanie Cohen Q&A How We Do It: From Awareness to Action: Improving Access to Hereditary Cancer Genetic Testing through Population Screening in a Community Health System, Allison DePersia & Breanne Prindeville & Yvette Shannon & Sarah Choi Q&A Ethical Considerations For The Future Of Population Based Genetic Testing, Julie Harris-Wai Q&A |
12:15 - 13:30 | LUNCH BREAK |
12:20 - 13:20 | Slot for Tier 1 Sponsored Lunch Symposium |
13:30 - 15:00 | Presidential Plenary III Moderators: Elana Levinson & TBA Systematic Functional Characterisation Of CDH1 Variants, Joseph (Sefi) Rosenbluh Somatic And Molecular Alterations In Colorectal Cancer By Birth Cohort, Ophir Gilad Causes Of Death Among Individuals With Lynch Syndrome (LS) In The Immunotherapy Era, Asaf Maoz Controversial Areas In Pancreatic Cancer Surveillance: A Survey Across The International Pancreatic Cancer Early Detection (PRECEDE) Consortium, Anjeli Manam Effect Of GLP-1 Receptor Agonist Use On Polyp Burden In Familial Adenomatous Polyposis: A Case Series, Diana Jomaa Beyond Familial Adenomatous Polyposis: Genotype-Phenotype Correlations Discern Germline Versus Somatic APC Whole-Gene Deletions Among 860,000 Tests, Katherine Belshe |
15:00 - 16:00 | CGA-IGC Business Meeting & Presidential Transition Beth Dudley Yurkovich & Mike Hall & Bryson Katona Post Meeting Wrap Up Elana Levinson |